Efficacy of factor IX Grifols® in surgery: experience of an international multicentre retrospective study

R. P ÉREZ-GARRIDO,* N. ALONSO,† V. J IMÉNEZ-YUSTE ,‡ S . HAYA,§ P . Z Ú Ñ IGA , ¶ A. BAQUES ,** M. CANDELA,** M. DÁVOLI†† and V . RESCIA†† *Hospital Virgen del Rocı́o, Sevilla; †Hospital Infanta Cristina, Badajoz; ‡Hospital Universitario La Paz, Madrid; §Hospital Universitario y Politécnico La Fe, Valencia, Spain; ¶Hospital de la Universidad Católica de Chile, Santiago, Chile; **Fundación de la Hemofilia, Buenos Aires; and ††Sanatorio Americano, Rosario, Argentina

[1]  D. Quon,et al.  Safety and efficacy of plasma‐derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  T. Lissitchkov,et al.  An open clinical study assessing the efficacy and safety of Factor IX Grifols®, a high‐purity Factor IX concentrate, in patients with severe haemophilia B , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  T. Lissitchkov,et al.  Pharmacokinetic study of a high‐purity factor IX concentrate (Factor IX Grifols®) with a 6‐month follow up in previously treated patients with severe haemophilia B , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[4]  C. Dash,et al.  A retrospective survey on the safety of Replenine®, a high‐purity factor IX concentrate , 2004, Pharmacoepidemiology and drug safety.

[5]  C. Leissinger,et al.  Continuous intravenous infusion of a plasma‐derived factor IX concentrate (Mononine®) in haemophilia B , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  C. Leissinger,et al.  Pharmacokinetic analysis of plasma‐derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B , 2002, Transfusion.

[7]  L. Aledort,et al.  Making a therapeutic choice: human versus recombinant fractions – can we do it? , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  S. Schulman,et al.  Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery , 1999, Haemophilia : the official journal of the World Federation of Hemophilia.